NEUPOGEN

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: a5b309b5b2fe4411
Drug Approval Canada Name: NEUPOGEN
Product Name: NEUPOGEN
Status: Marketed
Status Date: 2016-02-02
Original Market Date: 2016-02-02
Din: 02420112
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous , Intravenous
Schedule: Schedule D , Prescription
Ahfs: 20:16.00
Atc Original: L03AA02 FILGRASTIM
Atc Name: l 03 aa 02
Aig Number: 0123525003
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

FILGRASTIM

600 MCG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a5b309b5b2fe4411

Type

Standard